This page includes the latest FDA filings for Emergent Biosolutions Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
USA | NEW YORK STOCK EXCHANGE | EBS | DUNS 173570271 |
Device Company | Device | Date |
---|---|---|
Acrotech Biopharma LLC, Emergent BioSolutions, Inc. | Prescription Medication | 2024-05-18 |
Acrotech Biopharma LLC, Emergent BioSolutions, Inc. | Prescription Medication | 2024-04-18 |
Acrotech Biopharma LLC, Emergent BioSolutions, Inc. | Prescription Medication | 2023-03-06 |
Acrotech Biopharma LLC, Emergent BioSolutions, Inc. | Prescription Medication | 2020-11-25 |
Acrotech Biopharma LLC, Emergent BioSolutions, Inc. | Prescription Medication | 2020-02-26 |
Acrotech Biopharma LLC, Emergent BioSolutions, Inc. | Prescription Medication | 2020-01-24 |
Acrotech Biopharma LLC, Emergent BioSolutions, Inc. | Prescription Medication | 2019-10-15 |
NCAGE Code | 54KE5 | EMERGENT BIOSOLUTIONS INC. |
CAGE Code | 54KE5 | EMERGENT BIOSOLUTIONS INC. |
SEC | 0001367644 | Emergent BioSolutions Inc. of DELAWARE |